Ultrasound-guided stellate ganglion block for improving brain function in stroke patients

Ultrasound-guided stellate ganglion block for improving cerebral blood flow and brain function in stroke patients

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300072678

Enrollment

Unknown

Registered

2023-06-21

Start date

2022-01-01

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Group A:Ultrasound guided stellate ganglion block combined Comprehensive rehabilitation treatment

Group B (Control group):Comprehensive rehabilitation treatment

Eligibility

Sex/Gender

All

Age

30 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Patients with cerebral infarction or cerebral hemorrhage diagnosed by cranial computed tomography (CT) or magnetic resonance imaging (MRI) with reference to the 2010 edition of the "Guidelines for the Prevention and Treatment of Cerebrovascular Diseases in China", the condition is basically stable, without unconscious and obvious language barriers 2) Unilateral hemiplegia, NIHSS score > 3 and = 10 points or (and) Brunnstorm grade 15 (upper or lower extremity); 3) The patient's age is 30 to 85 years old; 4) Right-handed; 5) No clear diagnosis Mental illness; 6) No history of alcoholism and psychotropic drug dependence; 7) No severe cognitive impairment and aphasia.

Exclusion criteria

Exclusion criteria: 1) Patients with progressive disease or unstable vital signs in the acute stage of cerebrovascular disease; 2) Patients with severe cognitive impairment, audio-visual and speech impairment, coma, mental illness or post-stroke depression; 3) Severe heart, lung, liver and kidney damage 4) Combined with malignant tumor, brain tumor, traumatic brain injury, etc.; 5) Those who cannot actively cooperate with the treatment and quit halfway; 6) Those who are combined with other neurological diseases; 7) Those who have physical dysfunction caused by other diseases; 8) Alcoholism or taking Drugs that affect cortical excitability.

Design outcomes

Primary

Measure	Time frame
TCD;Vertebral and Carotid Ultrasound;Brain topography;	—

Secondary

Measure	Time frame
muscle strength;neurological deficit;Balance and Movement Function;activities of daily living;Pain, Sleep, Depression Scores;	—

Countries

China

Contacts

Public ContactSun Lin

the People's Hospital of Chongqing Liangjiang New Area

tilamisu789456123@126.com+86 150 8693 0644

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026